Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
<p>Abstract</p> <p>Background</p> <p>Nitric oxide (NO) produced in macrophages plays a pivotal role as a leishmanicidal agent. A previous study has demonstrated that 20% of the <it>L. (V.) braziliensis </it>isolated from initial cutaneous lesions of patients...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/10/209 |
id |
doaj-d17e47f834a440ab8a74dae15012455c |
---|---|
record_format |
Article |
spelling |
doaj-d17e47f834a440ab8a74dae15012455c2020-11-25T03:24:51ZengBMCBMC Infectious Diseases1471-23342010-07-0110120910.1186/1471-2334-10-209Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α productionWilson Mary Ede Moura Tatiana Rde Jesus Amelia RGuimarães Luís HPereira Júlia MBGiudice AngelaSouza Anselmo SCarvalho Edgar MAlmeida Roque P<p>Abstract</p> <p>Background</p> <p>Nitric oxide (NO) produced in macrophages plays a pivotal role as a leishmanicidal agent. A previous study has demonstrated that 20% of the <it>L. (V.) braziliensis </it>isolated from initial cutaneous lesions of patients from the endemic area of Corte de Pedra, Bahia, Brazil, were NO resistant. Additionally, 5 to 11% of the patients did not respond to three or more antimony treatments" (refractory patients). The aim of this study is to investigate if there is an association between the resistance of <it>L. (V.) braziliensis </it>to NO and nonresponsiveness to antimony therapy and cytokine production.</p> <p>Methods</p> <p>We evaluated the <it>in vitro </it>toxicity of NO against the promastigotes stages of <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients, and the infectivity of the amastigote forms of these isolates against human macrophages. The supernatants from <it>Leishmania </it>infected macrophage were used to measure TNF-α and IL-10 levels.</p> <p>Results</p> <p>Using NaNO<sub>2 </sub>(pH 5.0) as the NO source, <it>L. (V.) braziliensis </it>isolated from refractory patients were more NO resistant (IC50 = 5.8 ± 4.8) than <it>L. (V.) braziliensis </it>isolated from responsive patients (IC50 = 2.0 ± 1.4). Four isolates were selected to infect human macrophages: NO-susceptible and NO-resistant <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients. NO-resistant <it>L. (V.) braziliensis </it>isolated from refractory patients infected more macrophages stimulated with LPS and IFN-γ at 120 hours than NO-susceptible <it>L. (V.) braziliensis </it>isolated from refractory patients. Also, lower levels of TNF-α were detected in supernatants of macrophages infected with NO-resistant <it>L. (V.) braziliensis </it>as compared to macrophages infected with NO-susceptible <it>L. (V.) braziliensis </it>(p < 0.05 at 2, 24 and 120 hours), while no differences were detected in IL-10 levels.</p> <p>Conclusion</p> <p>These data suggest that NO resistance could be related to the nonresponsiveness to antimony therapy seen in American Tegumentary Leishmaniasis.</p> http://www.biomedcentral.com/1471-2334/10/209 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wilson Mary E de Moura Tatiana R de Jesus Amelia R Guimarães Luís H Pereira Júlia MB Giudice Angela Souza Anselmo S Carvalho Edgar M Almeida Roque P |
spellingShingle |
Wilson Mary E de Moura Tatiana R de Jesus Amelia R Guimarães Luís H Pereira Júlia MB Giudice Angela Souza Anselmo S Carvalho Edgar M Almeida Roque P Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production BMC Infectious Diseases |
author_facet |
Wilson Mary E de Moura Tatiana R de Jesus Amelia R Guimarães Luís H Pereira Júlia MB Giudice Angela Souza Anselmo S Carvalho Edgar M Almeida Roque P |
author_sort |
Wilson Mary E |
title |
Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production |
title_short |
Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production |
title_full |
Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production |
title_fullStr |
Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production |
title_full_unstemmed |
Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production |
title_sort |
resistance of <it>leishmania (viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and tnf-α production |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2010-07-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Nitric oxide (NO) produced in macrophages plays a pivotal role as a leishmanicidal agent. A previous study has demonstrated that 20% of the <it>L. (V.) braziliensis </it>isolated from initial cutaneous lesions of patients from the endemic area of Corte de Pedra, Bahia, Brazil, were NO resistant. Additionally, 5 to 11% of the patients did not respond to three or more antimony treatments" (refractory patients). The aim of this study is to investigate if there is an association between the resistance of <it>L. (V.) braziliensis </it>to NO and nonresponsiveness to antimony therapy and cytokine production.</p> <p>Methods</p> <p>We evaluated the <it>in vitro </it>toxicity of NO against the promastigotes stages of <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients, and the infectivity of the amastigote forms of these isolates against human macrophages. The supernatants from <it>Leishmania </it>infected macrophage were used to measure TNF-α and IL-10 levels.</p> <p>Results</p> <p>Using NaNO<sub>2 </sub>(pH 5.0) as the NO source, <it>L. (V.) braziliensis </it>isolated from refractory patients were more NO resistant (IC50 = 5.8 ± 4.8) than <it>L. (V.) braziliensis </it>isolated from responsive patients (IC50 = 2.0 ± 1.4). Four isolates were selected to infect human macrophages: NO-susceptible and NO-resistant <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients. NO-resistant <it>L. (V.) braziliensis </it>isolated from refractory patients infected more macrophages stimulated with LPS and IFN-γ at 120 hours than NO-susceptible <it>L. (V.) braziliensis </it>isolated from refractory patients. Also, lower levels of TNF-α were detected in supernatants of macrophages infected with NO-resistant <it>L. (V.) braziliensis </it>as compared to macrophages infected with NO-susceptible <it>L. (V.) braziliensis </it>(p < 0.05 at 2, 24 and 120 hours), while no differences were detected in IL-10 levels.</p> <p>Conclusion</p> <p>These data suggest that NO resistance could be related to the nonresponsiveness to antimony therapy seen in American Tegumentary Leishmaniasis.</p> |
url |
http://www.biomedcentral.com/1471-2334/10/209 |
work_keys_str_mv |
AT wilsonmarye resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT demouratatianar resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT dejesusameliar resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT guimaraesluish resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT pereirajuliamb resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT giudiceangela resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT souzaanselmos resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT carvalhoedgarm resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction AT almeidaroquep resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction |
_version_ |
1724599483431387136 |